Article

WaveLight expands U.S. management team, appoints CFO

WaveLight Inc. announces that Ken Nelson has joined the company as chief financial officer (CFO). Nelson will oversee finance-related strategic and operational decisions for the U.S. subsidiary of WaveLight AG.

WaveLight Inc. announces that Ken Nelson has joined the company as chief financial officer (CFO). Nelson will oversee finance-related strategic and operational decisions for the U.S. subsidiary of WaveLight AG.

The appointment strengthens the U.S. executive management team led by Chief Executive Officer Wolfgang Tolle that includes Blake Michaels, vice president of sales; Luca Sergio, vice president of marketing; Ric Tiplady, vice president of business development; and Beth Martinko, vice president of customer service.

"With three decades of international finance and operational experience, Ken Nelson has the practical insight to help guide WaveLight Inc. to its next stage of evolution," Tolle said. "Acquiring such a seasoned CFO, along with the other highly experienced members of our management team, demonstrates our commitment to further grow the company, broaden our leadership position in the refractive laser industry, and provide unparalleled support to our burgeoning customer base."

With more than 30 years of international financial and operational experience in both public and private companies, Nelson most recently was a managing partner with London-based Highgate Associates LLC, where he raised more than $65 million and completed six divestitures and four European acquisitions.

For more information, visit WaveLight at Booth 1331.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.